Model-informed drug development (MIDD) is a powerful quantitative approach that plays an integral role in drug development and regulatory review. While applied throughout the life cycle of …
Dose Optimization Informed by PBPK Modeling: State-of-the Art and Future
May 6, 2024
Author(s): Karen Rowland Yeo, Eva Gil Berglund, Yuan Chen
Year: April 30, 2024